(Q62820368)
Statements
NASHPro (English)
0 references
Evaluation of Alterations in Serum Inflammatory Markers and Fecal Microbiota Following Administration of the Probiotic Formulation VSL#3 in Patients With Nonalcoholic Fatty Liver Disease (English)
0 references
15 May 2018
0 references
June 2019
0 references
20
0 references
18 year
0 references